Investors who own more than 5% of a class must file a Schedule 13D or 13G. Each filer's latest filing for 74346M505 since 12/18/2024, largest first.
| Filer | % of Class | Filed | |
|---|---|---|---|
|
ABG Management Ltd.
13D/A
|
17.0% |
2/5/2026
Event 2/3/2026
|
|
| ABG Management Ltd. | 6.3% | ||
| Ally Bridge Group (NY) LLC | 6.3% | ||
| Ally Bridge MedAlpha Master Fund L.P. | 6.3% | ||
| ABG V-SIV IX Limited | 7.1% | ||
| Ally Bridge Group Global Life Science Capital Partners V, L.P. | 7.1% | ||
| ABG Global Life Science Capital Partners V GP, L.P. | 7.1% | ||
| ABG Global Life Science Capital Partners V GP Limited | 7.1% | ||
| ABG V-SIV X Limited | 4.5% | ||
| Fan Yu | 17.0% | ||
| Janus Henderson Group PLC 13G | 14.4% |
4/7/2026
Event 3/31/2026
|
|
|
Deep Track Capital, LP
13G
|
10.0% |
2/6/2026
Event 1/30/2026
|
|
| Deep Track Capital, LP | 10.0% | ||
| Deep Track Biotechnology Master Fund, Ltd. | 7.8% | ||
| David Kroin | 10.0% | ||
| Deep Track Special Opportunities Fund, LP. | 2.2% | ||
|
Trails Edge Capital Partners, LP
13G
|
9.9% |
2/10/2026
Event 2/3/2026
|
|
| Trails Edge Capital Partners, LP | 9.9% | ||
| Trails Edge Biotechnology Master Fund, LP | 9.9% | ||
| Ortav Yehudai | 9.9% | ||
|
Wellington Management Group LLP
13G/A
|
7.8% |
8/13/2026
Event 6/30/2026
|
|
| Wellington Management Group LLP | 7.8% | ||
| Wellington Group Holdings LLP | 7.8% | ||
| Wellington Investment Advisors Holdings LLP | 7.8% | ||
| Wellington Management Company LLP | 7.8% | ||
| Wellington Biomedical Innovation Master Investors (Cayman) II L.P. 13G/A | 7.8% |
8/13/2026
Event 6/30/2026
|
|
|
Great Point Partners, LLC
13G/A
|
7.7% |
8/14/2026
Event 6/30/2026
|
|
| Great Point Partners, LLC | 7.7% | ||
| Dr. Jeffrey R. Jay, M.D. | 7.7% | ||
| Ms. Lillian Nordahl | 7.7% |